Atlas Trials

Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus

Clinical trial NCT00507793 · COMPLETED

Trial details

NCT number
NCT00507793
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney Transplantation
Start date
2000-04-01
Enrollment
385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.